What the Creatine Research Actually Shows

The Most Replicated Supplement in Sports Science

Creatine monohydrate has over 1,000 published studies and a safety and efficacy profile unmatched by any other supplement. The effect on short-duration high-intensity exercise is one of the most robust findings in sports nutrition — yet its mechanisms and optimal use are still frequently misunderstood.

What Replicates Strongly

Creatine supplementation increases phosphocreatine stores by 10–40%, improving high-intensity performance. The mechanism is straightforward: phosphocreatine rapidly regenerates ATP during maximal efforts lasting 1–30 seconds. RCTs consistently show improvements in sprint performance, maximal strength, and power output. Effects are largest in people with lower baseline creatine stores (vegetarians, low red meat consumers).

Muscle mass gains from creatine are real but partly water-mediated. Short-term mass increases (1–2kg in loading phase) are predominantly intramuscular water. Long-term studies (8–12 weeks) show genuine dry muscle mass accretion beyond water, driven by increased training volume capacity and anabolic signalling. The net effect on lean mass is consistently positive across meta-analyses (ES ~0.36 kg beyond placebo).

Cognitive benefits are real but context-dependent. RCTs show creatine improves working memory, fluid intelligence, and processing speed primarily under conditions of mental fatigue, sleep deprivation, or caloric restriction. Effects on well-rested, well-nourished participants are smaller. A 2022 meta-analysis of 10 RCTs found significant cognitive improvements, particularly for tasks involving speed and memory consolidation.

5g/day without loading is as effective as loading protocols over 4 weeks. Loading (20g/day × 5–7 days) saturates stores faster but achieves the same endpoint as daily 3–5g supplementation by week 4. Loading is useful only if you need faster performance benefits.

Creatine is safe for long-term use in healthy individuals. Decade-long follow-up studies and a comprehensive meta-analysis show no adverse renal, hepatic, or cardiovascular effects at recommended doses. The "damages kidneys" myth persists despite being repeatedly refuted in controlled research.

What the Research Can't Tell You

Response rates vary substantially — about 25–30% of people are "non-responders" with minimal phosphocreatine increases from supplementation, typically those with already-high baseline stores. If you're not observing performance benefits after 4 weeks of consistent use, you may be in this group. Testing pre/post strength performance is the only way to identify this individually.